Factors of faecal microbiota transplantation applied to cancer management.

The homeostasis of the microbiota is essential for human health. In particular, the gut microbiota plays a critical role in the regulation of the immune system. Thus, faecal microbiota transplantation (FMT), a technology that has rapidly developed in the last decade, has specifically been utilised for the treatment of intestinal inflammation and has recently been found to be able to treat tumours in combination with immunotherapy. FMT has become a breakthrough in enhancing the response rate to immunotherapy in cancer patients by altering the composition of the patient's gut microbiota. This review discusses the mechanisms of faecal microorganism effects on tumour development, drug treatment efficacy, and adverse effects and describes the recent clinical research trials on FMT. Moreover, the factors influencing the efficacy and safety of FMT are described. We summarise the possibilities of faecal transplantation in the treatment of tumours and its complications and propose directions to explore the development of FMT.

[3]Pseudorotaxane-like complexes formed between bipyridinium dications and bis-p-xylyl[26]crown-6.

[structure: see text]. The crown ether BPX26C6 forms a [3]pseudorotaxane-like complex with the N,N'-dimethyl-4,4'-bipyridinium dication both in solution and in the solid state. The facile one-pot synthesis of a [2]rotaxane from neutral precursors-BPX26C6, 4,4'-dipyridyl, and 3,5-di-tert-butylbenzyl bromide-suggests that BPX26C6 may bind to (mono)pyridinium cations in a [2]pseudorotaxane-like manner.